The usefulness of the standardized analysis strategy previously described for the determination of basic drugs in pharmaceutical dosage forms is evaluated. Several examples which typify experience in applying the strategy are reported. Ion-pair extraction techniques are compared with each other and with a classical extraction method in terms of their efficiency. The extraction technique with di(2-ethylhexyl)-phosphoric acid (HDEHP) is found to be the method of choice. The use of an internal standard is recommended. The selection of a suitable compound is greatly facilitated by referring to the chromatographic properties. It is shown that it is not necessary for the analyte and internal standard to be structurally similar. The combination of the HDEHP extraction technique with the preferred HPLC systems has been shown to be very useful in the routine analysis of pharmaceutical dosage forms.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0731-7085(84)80048-5DOI Listing

Publication Analysis

Top Keywords

pharmaceutical dosage
12
dosage forms
12
standardized analysis
8
analysis strategy
8
basic drugs
8
ion-pair extraction
8
analysis pharmaceutical
8
extraction technique
8
internal standard
8
extraction
5

Similar Publications

Nasal spray treatments that inhibit the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) entry into nose and nasopharynx at early stages can be an appropriate approach to stop or delay the progression of the disease. We performed a prospective, randomized, double-blind, placebo-controlled, parallel-group, multicentric, phase II clinical trial comparing the rate of hospitalization due to COVID-19 infection between azelastine 0.1% nasal spray and placebo nasal spray treatment groups.

View Article and Find Full Text PDF

The combination of isoniazid (INH) and rifampicin (RIF) is indicated for the treatment maintenance phase of tuberculosis (TB) in adults and children. In Brazil, there is no current reference listed drug for this indication in children. Farmanguinhos has undertaken the development of an age-appropriate dispersible tablet to be taken with water for all age groups from birth to adolescence.

View Article and Find Full Text PDF

Patient care and control of inflammatory disorders, such as psoriasis, can be improved by model-informed precision dosing (MIPD) techniques based on population pharmacokinetic/pharmacodynamic (PK/PD) models. Clinical dose selection decisions based on MIPD strategies need to take account of the uncertainty associated with the individual PK/PD model parameters, which is determined by the quantity of individual observational data collected in clinical practice. The aim of this study was to propose an approach for personalized dosage regimens of secukinumab (SCK) in 22 Spanish patients with plaque psoriasis, whose severity level was considered moderate to severe, taking into account the uncertainty associated with individual parameters in a population-based PK/PD model.

View Article and Find Full Text PDF

Advances in Research of Hydrogel Microneedle-Based Delivery Systems for Disease Treatment.

Pharmaceutics

December 2024

National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu 610065, China.

Microneedles (MNs), composed of multiple micron-scale needle-like structures attached to a base, offer a minimally invasive approach for transdermal drug delivery by penetrating the stratum corneum and delivering therapeutic agents directly to the epidermis or dermis. Hydrogel microneedles (HMNs) stand out among various MN types due to their excellent biocompatibility, high drug-loading capacity, and tunable drug-release properties. This review systematically examines the matrix materials and fabrication methods of HMN systems, highlighting advancements in natural and synthetic polymers, and explores their applications in treating conditions such as wound healing, hair loss, cardiovascular diseases, and cancer.

View Article and Find Full Text PDF

Buccal drug delivery emerges as a promising strategy to enhance the absorption of drugs classified under the Biopharmaceutics Classification System (BCS) Class III, characterized by high solubility and low permeability. However, addressing the absorption challenges of BCS Class III drugs necessitates innovative formulation strategies. This review delves into optimizing buccal drug delivery for BCS III drugs, focusing on various formulation approaches to improve absorption.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!